Incidence of intraocular pressure spike and other adverse events after vitreoretinal surgery

Nicholas Anderson, Mitchell S. Fineman, Gary C. Brown

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Purpose: To determine the incidence of significant postoperative intraocular pressure (IOP) elevation and other adverse medical events during the first postoperative day in patients undergoing inpatient vitreoretinal surgery. Design: Noncomparative interventional case series. Participants: Two hundred two consecutive patients were admitted prospectively as inpatients after vitreoretinal surgery (vitrectomy and/or scleral buckling). Methods: Intraocular pressure was measured preoperatively, 5 to 12 hours postoperatively, and on postoperative day 1. Additionally, pain, nausea, and serious systemic adverse events were monitored. Results: Seventeen patients (8.4%) had a 5- to 12-hour IOP measurement above 29 mmHg. Thirty patients (14.8%) had a postoperative day 1 IOP measurement above 29 mmHg. Three patients (1.5%) required a parenteral narcotic to achieve adequate analgesia. Nine patients (4.5%) utilized a parenteral antiemetic for nausea control. Six patients (3.0%) had a hyperglycemic event. No serious systemic adverse events occurred in the early postoperative period. Conclusions: The incidence of a significant IOP spike or systemic adverse events in the early postoperative period in patients undergoing vitreoretinal surgery is low.

Original languageEnglish (US)
Pages (from-to)42-47
Number of pages6
JournalOphthalmology
Volume113
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Vitreoretinal Surgery
Intraocular Pressure
Incidence
Postoperative Period
Nausea
Inpatients
Scleral Buckling
Antiemetics
Narcotics
Vitrectomy
Analgesia
Pain

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

Incidence of intraocular pressure spike and other adverse events after vitreoretinal surgery. / Anderson, Nicholas; Fineman, Mitchell S.; Brown, Gary C.

In: Ophthalmology, Vol. 113, No. 1, 01.01.2006, p. 42-47.

Research output: Contribution to journalArticle

Anderson, Nicholas ; Fineman, Mitchell S. ; Brown, Gary C. / Incidence of intraocular pressure spike and other adverse events after vitreoretinal surgery. In: Ophthalmology. 2006 ; Vol. 113, No. 1. pp. 42-47.
@article{30e8611e2ac14950b2cdc7ae7e783abf,
title = "Incidence of intraocular pressure spike and other adverse events after vitreoretinal surgery",
abstract = "Purpose: To determine the incidence of significant postoperative intraocular pressure (IOP) elevation and other adverse medical events during the first postoperative day in patients undergoing inpatient vitreoretinal surgery. Design: Noncomparative interventional case series. Participants: Two hundred two consecutive patients were admitted prospectively as inpatients after vitreoretinal surgery (vitrectomy and/or scleral buckling). Methods: Intraocular pressure was measured preoperatively, 5 to 12 hours postoperatively, and on postoperative day 1. Additionally, pain, nausea, and serious systemic adverse events were monitored. Results: Seventeen patients (8.4{\%}) had a 5- to 12-hour IOP measurement above 29 mmHg. Thirty patients (14.8{\%}) had a postoperative day 1 IOP measurement above 29 mmHg. Three patients (1.5{\%}) required a parenteral narcotic to achieve adequate analgesia. Nine patients (4.5{\%}) utilized a parenteral antiemetic for nausea control. Six patients (3.0{\%}) had a hyperglycemic event. No serious systemic adverse events occurred in the early postoperative period. Conclusions: The incidence of a significant IOP spike or systemic adverse events in the early postoperative period in patients undergoing vitreoretinal surgery is low.",
author = "Nicholas Anderson and Fineman, {Mitchell S.} and Brown, {Gary C.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/j.ophtha.2005.10.010",
language = "English (US)",
volume = "113",
pages = "42--47",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Incidence of intraocular pressure spike and other adverse events after vitreoretinal surgery

AU - Anderson, Nicholas

AU - Fineman, Mitchell S.

AU - Brown, Gary C.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Purpose: To determine the incidence of significant postoperative intraocular pressure (IOP) elevation and other adverse medical events during the first postoperative day in patients undergoing inpatient vitreoretinal surgery. Design: Noncomparative interventional case series. Participants: Two hundred two consecutive patients were admitted prospectively as inpatients after vitreoretinal surgery (vitrectomy and/or scleral buckling). Methods: Intraocular pressure was measured preoperatively, 5 to 12 hours postoperatively, and on postoperative day 1. Additionally, pain, nausea, and serious systemic adverse events were monitored. Results: Seventeen patients (8.4%) had a 5- to 12-hour IOP measurement above 29 mmHg. Thirty patients (14.8%) had a postoperative day 1 IOP measurement above 29 mmHg. Three patients (1.5%) required a parenteral narcotic to achieve adequate analgesia. Nine patients (4.5%) utilized a parenteral antiemetic for nausea control. Six patients (3.0%) had a hyperglycemic event. No serious systemic adverse events occurred in the early postoperative period. Conclusions: The incidence of a significant IOP spike or systemic adverse events in the early postoperative period in patients undergoing vitreoretinal surgery is low.

AB - Purpose: To determine the incidence of significant postoperative intraocular pressure (IOP) elevation and other adverse medical events during the first postoperative day in patients undergoing inpatient vitreoretinal surgery. Design: Noncomparative interventional case series. Participants: Two hundred two consecutive patients were admitted prospectively as inpatients after vitreoretinal surgery (vitrectomy and/or scleral buckling). Methods: Intraocular pressure was measured preoperatively, 5 to 12 hours postoperatively, and on postoperative day 1. Additionally, pain, nausea, and serious systemic adverse events were monitored. Results: Seventeen patients (8.4%) had a 5- to 12-hour IOP measurement above 29 mmHg. Thirty patients (14.8%) had a postoperative day 1 IOP measurement above 29 mmHg. Three patients (1.5%) required a parenteral narcotic to achieve adequate analgesia. Nine patients (4.5%) utilized a parenteral antiemetic for nausea control. Six patients (3.0%) had a hyperglycemic event. No serious systemic adverse events occurred in the early postoperative period. Conclusions: The incidence of a significant IOP spike or systemic adverse events in the early postoperative period in patients undergoing vitreoretinal surgery is low.

UR - http://www.scopus.com/inward/record.url?scp=29644447976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29644447976&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2005.10.010

DO - 10.1016/j.ophtha.2005.10.010

M3 - Article

C2 - 16360213

AN - SCOPUS:29644447976

VL - 113

SP - 42

EP - 47

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 1

ER -